Western Blot: UCH-L1/PGP9.5 Antibody (BH7) [NB110-58869] - Analysis of tissue lysates using mouse mAb to UCHL1, NB110-58869, dilution 1:10,000 in green: [1] protein standard (red), [2] rat brain, [3] rat spinal cord, ...read more
Immunocytochemistry/ Immunofluorescence: PGP9.5 / UCHL-1 Antibody (BH7) [NB110-58869] - Shows human embryonic kidney cell line 293 stained with mouse monoclonal to UCHL1 (NB110-58869) (green) and rabbit antibody to ...read more
Immunohistochemistry Free-Floating: UCH-L1/PGP9.5 Antibody (BH7) [NB110-58869] - Analysis of rat hippocampal section stained with mouse mAb to UCHL1, NB110-58869, dilution 1:5,000 in green and costained with rabbit pAb ...read more
Simple Western: PGP9.5 / UCHL-1 Antibody (BH7) [NB110-58869] - Simple Western lane view shows a specific band for PGP9.5/UCHL-1 in 0.02 mg/ml of Human Brain lysate. This experiment was performed under reducing ...read more
This UCHL1 antibody is useful for Immunocytochemistry/Immunofluorescence, Immunohistochemistry and Western Blot, where a band can be seen at approximately 24 kDa.
In Simple Western only 10 - 15 uL of the recommended dilution is used per data point. Separated by Size-Wes, Sally Sue/Peggy Sue.
Theoretical MW
24 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
UCH-L1 (ubiquitin carboxyl-terminal hydrolase isozyme L1) was the first discovered de-ubiquitinating enzyme which implicates in processing of ubiquitin precursors and also of ubiquitinated proteins. UCH-L1 is a thiol protease that recognizes and hydrolyzes a peptide bond at C-terminal glycine of ubiquitin. It also binds to free monoubiquitin and prevents its degradation in lysosomes. Localized in cytoplasm and ER membrane as lipid-anchor, UCH-L1 expression is restricted to brain, peripheral nerves, endocrine tissues and gonads of both sexes etc. UCH-L1 deletion in mice leads to fatal neurodegenerative disorder known as gracile axonal dystrophy and it is down-regulated in brains from Parkinson as well as Alzheimer disease patients. Expression outside of neuro-endocrine tissues is found in various cancers including B-cell lymphoma, multiple myeloma, and lung cancer. In transgenic mouse model, UCH-L1 has been demonstrated as an oncogene that causes malignancies by boosting AKT signalling. Furthermore, UCH-L1 has been shown to interfere with ubiquitination of RAPTOR which is catalyzed by DDB1-Cul4 E3 ligase complex, leading to loss of mTORC1 integrity accompanied by a concurrent increase in mTORC2, likely due to increased availability of free mTOR.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Reviews for UCH-L1/PGP9.5 Antibody (NB110-58869) (0)
There are no reviews for UCH-L1/PGP9.5 Antibody (NB110-58869).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our UCH-L1/PGP9.5 Antibody (BH7) and receive a gift card or discount.